JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosoya, E.
Right arrow Articles by Brody, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosoya, E.
Right arrow Articles by Brody, T. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 120, Issue 4, 504-511, 1957
Copyright © 1957 by American Society for Pharmacology and Experimental Therapeutics


IN VITRO OXIDATION OF MORPHINE BY RAT TISSUE HOMOGENATES

Eikichi Hosoya 1 and Theodore M. Brody 1

1 Dept. of Pharmacology, University of Michigan Medical School, Ann Arbor

Morphine, in the presence of cytochrome c, is oxidized by rat tissue homogenates to a compound which is indistinguishable from pseudomorphine by chromatographic analysis. The addition of cytochrome c to these homogenates causes a concomitant fall in glucuronide synthesis. The capacity to oxidize morphine is intimately associated with the cytochrome enzymes. Nalorphine, heterocodeine and dihydromorphinone, compounds having free phenolic hydroxyl groups, are oxidized under similar conditions, codeine is not transformed in this manner. The pharmacological implications of these findings are discussed.

Submitted on March 28, 1957







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1957 by the American Society for Pharmacology and Experimental Therapeutics.